1. TFCP2 as a therapeutic nexus: unveiling molecular signatures in cancer
    Neha Kaushik et al, 2024, Cancer and Metastasis Reviews CrossRef
  2. High expression of tumor susceptibility gene 101 (TSG101) is associated with more aggressive behavior in colorectal carcinoma
    Elmira Gheytanchi et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
  3. Diagnostic and prognostic relevance of CP2c and YY1 expression in hepatocellular carcinoma
    Ji Sook Kim et al, 2017, Oncotarget CrossRef
  4. TFCP2/TFCP2L1/UBP1 transcription factors in cancer
    Grzegorz Kotarba et al, 2018, Cancer Letters CrossRef
  5. Analysis of the Expression of LSF Transcription Factor in the Regulation of Transcription and TSG101 during the Neoplastic Transformation of Endometrial Cells
    Rafał Ziemiński et al, 2024, Cells CrossRef
  6. Prognostic Implication of YY1 and CP2c Expression in Patients with Primary Breast Cancer
    Chihwan David Cha et al, 2023, Cancers CrossRef
  7. Pharmacologic Manipulation of Late SV40 Factor Suppresses Wnt Signaling and Inhibits Growth of Allogeneic and Syngeneic Colon Cancer Xenografts
    Saran Lotfollahzadeh et al, 2022, The American Journal of Pathology CrossRef
  8. Metformin disrupts malignant behavior of oral squamous cell carcinoma via a novel signaling involving Late SV40 factor/Aurora-A
    Chang-Han Chen et al, 2017, Scientific Reports CrossRef
  9. Epithelioid and spindle cell rhabdomyosarcoma with FUS-TFCP2 or EWSR1-TFCP2 fusion: report of two cases
    John S.A. Chrisinger et al, 2020, Virchows Archiv CrossRef